Technology | PACS | January 22, 2018

QualiTest Releases Virtual Radiology Environment 2.0 PACS Testing Solution

Comprehensive DICOM and HL7 testing solution offers enhanced crowd testing and smarter artificial intelligence

January 22, 2018 — QualiTest Group recently announced its improved Virtual Radiology Environment (VRE) testing solution for picture archiving and communication systems (PACS). The offering builds upon the original solution with enhanced crowd testing and artificial intelligence (AI) capabilities, enabling vendors to scale more quickly.

QualiTest’s VRE automation accelerator tests PACS for scalability and reliability, delivering a comprehensive answer for synchronized Digital Imaging and Communications in Medicine (DICOM) and Health Level 7 (HL7) traffic. The VRE solution increases DICOM and HL7 test coverage, reducing efforts and cost by up to 80 percent. Integrating seamlessly with the latest automation tools, the solution supports external scripting and merges fully with all other AI-driven systems.  

As healthcare providers have grown increasingly dependent upon the reliability and scalability of PACS, these systems have become increasingly complex and vendors have witnessed them receive more data than they ever anticipated. However, though features can be verified simply, scalability is challenging to test. QualiTest’s VRE solves this problem by enabling vendors to simulate all the network patterns and data flows that naturally occur in the radiology industry, using its enhanced AI capabilities to generate extensive volumes of data from limited sets of inputs.

QualiTest demonstrated the VRE solution at the 2017 Radiological Society of North America (RSNA) Annual Meeting, Nov. 26-Dec. 1 in Chicago.

For more information: www.qualitestgroup.com

 

Related Content

John Carrino, M.D., M.Ph., presents “Challenges and Opportunities for Radiology to Prove Value in Alternative Payment Models” at AHRA 2019

John Carrino, M.D., M.Ph., presents “Challenges and Opportunities for Radiology to Prove Value in Alternative Payment Models” at AHRA 2019. Photo by Greg Freiherr

Feature | Radiology Business | July 22, 2019 | By Greg Freiherr
Efforts to reform healthcare are booming, b
IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017.

IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017, and who had health records for at least one year prior to the mammogram. The algorithm was trained on 9,611 mammograms. Image courtesy of Radiology.

Feature | Artificial Intelligence | July 19, 2019 | Michal Chorev
Breast cancer is the global leading cause of cancer-related deaths in women, and the most commonly diagnosed cancer...
Paragon Biosciences Launches Qlarity Imaging to Advance FDA-cleared AI Breast Cancer Diagnosis System

Qlarity Imaging’s software is used to assist radiologists in the assessment and characterization of breast lesions. Imaging features are synthesized by an artificial intelligence algorithm into a single value, the QI score, which is analyzed relative to a database of reference abnormalities with known ground truth. Image courtesy of Business Wire.

Technology | Artificial Intelligence | July 18, 2019
Paragon Biosciences LLC announced the launch of its seventh portfolio company, Qlarity Imaging LLC, which was founded...
Graphic courtesy Pixabay

Graphic courtesy Pixabay

Feature | Artificial Intelligence | July 15, 2019 | By Greg Freiherr
Siemens has long focused on automation as a way to make diagnostic equipment faster and more efficient.
Videos | Artificial Intelligence | July 12, 2019
Khan Siddiqui, M.D., founder and CEO of HOPPR, discusses the economic advantages and costs presented by...
Videos | Digital Pathology | July 11, 2019
Toby Cornish, M.D., Ph.D., associate professor and medical director of informatics at the University of Colorado Scho
FDA Clears Koios DS Breast 2.0 AI-based Software
News | Ultrasound Women's Health | July 11, 2019
Koios Medical announced its second 510(k) clearance from the U.S. Food and Drug Administration (FDA).
SimonMed Imaging Implements ProFound AI for 3-D Tomosynthesis
News | Mammography | July 10, 2019
Arizona-based SimonMed Imaging announced their implementation of the first U.S. Food and Drug Administration (FDA)-...